Form 8-K - Current report:
SEC Accession No. 0001609550-21-000046
Filing Date
2021-11-02
Accepted
2021-11-02 16:12:13
Documents
14
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insp-20211102.htm   iXBRL 8-K 35009
2 EX-99.1 insp2021-q3pressreleaseex9.htm EX-99.1 103873
6 new20logo20on20whitea.jpg GRAPHIC 36188
  Complete submission text file 0001609550-21-000046.txt   335172

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT insp-20211102.xsd EX-101.SCH 1974
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT insp-20211102_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT insp-20211102_pre.xml EX-101.PRE 13115
7 EXTRACTED XBRL INSTANCE DOCUMENT insp-20211102_htm.xml XML 10982
Mailing Address 5500 WAYZATA BLVD SUITE 1600 GOLDEN VALLEY MN 55416
Business Address 5500 WAYZATA BLVD SUITE 1600 GOLDEN VALLEY MN 55416 763-957-5037
Inspire Medical Systems, Inc. (Filer) CIK: 0001609550 (see all company filings)

EIN.: 261377674 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38468 | Film No.: 211371440
SIC: 3841 Surgical & Medical Instruments & Apparatus